Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Leboulleux

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|June 26, 2008
Prognostic role of undetectable ablation thyroglobulin and follow-up thyroglobulin in patients with thyroid cancerSophie Leboulleux
F1000Prime Reports|March 10, 2015
Treatment of distant metastases from follicular cell-derived thyroid cancerMartin Schlumberger, Sophie Leboulleux
Nature Reviews. Endocrinology|December 19, 2020
Current practice in patients with differentiated thyroid cancerMartin Schlumberger, Sophie Leboulleux
Revue Medicale Suisse|January 20, 2022
[What's new in endocrinology]Maria Mavromati, Sophie Leboulleux
La Revue Du Praticien|December 5, 2018
Medullary thyroid cancer is rare but inherited in 25% of casesMartin Schlumberger, Julien Hadoux, Sophie Leboulleux
La Revue Du Praticien|December 5, 2018
Anaplastic cancer of the thyroid, a rare and very aggressive cancerMartin Schlumberger, Julien Hadoux, Sophie Leboulleux
La Revue Du Praticien|December 5, 2018
Treatment of differentiated thyroid cancersSophie Leboulleux, Amandine Berdelou, Dana Hartl
Nature Reviews. Endocrinology|June 21, 2022
Post-operative radioactive iodine administration in patients with low-risk thyroid cancerSophie Leboulleux, Isabelle Borget, Martin Schlumberger
The Lancet. Diabetes & Endocrinology|January 22, 2021
Thyroid cancer incidence in children and adolescentsLivia Lamartina, Sophie Leboulleux, Martin Schlumberger
The Lancet. Diabetes & Endocrinology|August 26, 2018
Radioactive iodine ablation in low-risk thyroid cancer - Authors' replySophie Leboulleux, Isabelle Borget, Martin Schlumberger
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Nature Clinical Practice. Endocrinology & Metabolism|June 26, 2008
Prognostic role of undetectable ablation thyroglobulin and follow-up thyroglobulin in patients with thyroid cancerSophie Leboulleux
F1000Prime Reports|March 10, 2015
Treatment of distant metastases from follicular cell-derived thyroid cancerMartin Schlumberger, Sophie Leboulleux
Nature Reviews. Endocrinology|December 19, 2020
Current practice in patients with differentiated thyroid cancerMartin Schlumberger, Sophie Leboulleux
Revue Medicale Suisse|January 20, 2022
[What's new in endocrinology]Maria Mavromati, Sophie Leboulleux
La Revue Du Praticien|December 5, 2018
Medullary thyroid cancer is rare but inherited in 25% of casesMartin Schlumberger, Julien Hadoux, Sophie Leboulleux
La Revue Du Praticien|December 5, 2018
Anaplastic cancer of the thyroid, a rare and very aggressive cancerMartin Schlumberger, Julien Hadoux, Sophie Leboulleux
La Revue Du Praticien|December 5, 2018
Treatment of differentiated thyroid cancersSophie Leboulleux, Amandine Berdelou, Dana Hartl
Nature Reviews. Endocrinology|June 21, 2022
Post-operative radioactive iodine administration in patients with low-risk thyroid cancerSophie Leboulleux, Isabelle Borget, Martin Schlumberger
The Lancet. Diabetes & Endocrinology|January 22, 2021
Thyroid cancer incidence in children and adolescentsLivia Lamartina, Sophie Leboulleux, Martin Schlumberger
The Lancet. Diabetes & Endocrinology|August 26, 2018
Radioactive iodine ablation in low-risk thyroid cancer - Authors' replySophie Leboulleux, Isabelle Borget, Martin Schlumberger
Pageof 22